Actinobacillus pleuropneumoniae: Pathogenesis, Virulence, Diagnostics, and Molecular Epidemiology
Etiology and Taxonomy
Actinobacillus pleuropneumoniae (App) is a Gram-negative, rod-shaped bacterium belonging to the family Pasteurellaceae [1, 2, 3]. It is the causative agent of porcine pleuropneumonia, a highly contagious and often fatal respiratory disease that causes substantial economic losses in the swine industry worldwide [4, 1, 5]. The pig (Sus scrofa domesticus) is its only known natural host [1]. The organism is a facultative anaerobe that requires nicotinamide adenine dinucleotide (NAD; V factor) for growth, classifying most clinical isolates as biovar 1 [6, 7]. Biovar 2 strains, which are NAD-independent, are rarely isolated from clinical cases [7].
To date, 19 distinct serovars have been described based on the antigenic diversity of the capsular polysaccharide (CPS) and the lipopolysaccharide (LPS) O-antigen [6, 8, 9]. The reference strain for serovar 19 was proposed from a Danish isolate (7213384-1), which possesses a novel type II capsule locus [6, 10]. The serovar classification is critical for epidemiological surveillance and for informing vaccine formulation, as immunity is largely serovar-specific [8, 2, 5].
Host Range and Clinical Significance
Pleuropneumonia in swine can manifest as peracute, acute, or chronic disease [1, 5]. Peracute cases are characterized by sudden death with minimal premonitory signs, and the time from infection to death can be as short as 6 hours [1]. Acute disease presents with high fever, apathy, anorexia, severe respiratory distress, and cyanosis [1, 5]. Chronic infections are often subclinical but result in reduced growth performance and serve as a reservoir for transmission within herds [1, 5, 11]. Characteristic lung lesions include fibrinohemorrhagic and necrotizing pleuropneumonia, often with severe pleural adhesions in chronic cases [1, 5, 11]. The diagnostic approach and lesion presentation are detailed further in the related article on Actinobacillus pleuropneumoniae (APP) in Pigs: Fibrinohemorrhagic Pleuropneumonia and Diagnosis.
Virulence Factors and Pathogenesis
The pathogenesis of A. pleuropneumoniae is multifactorial, involving a suite of virulence determinants that facilitate colonization, immune evasion, and tissue destruction [4, 2].
RTX Toxins
The major virulence determinants are the Repeat in ToXin (RTX) exotoxins, ApxI, ApxII, ApxIII, and the species-specific ApxIV [4, 12, 8, 2]. ApxI is strongly hemolytic and cytotoxic; ApxII is moderately hemolytic and cytotoxic; ApxIII is non-hemolytic but highly cytotoxic [4, 2, 7]. The specific combination of apx operons (apxCABD) largely defines the serovar and the virulence profile of a given strain [12, 8, 7]. For example, serovar 2 isolates typically produce ApxII and ApxIII, while serovar 9 and 16 isolates produce ApxI and ApxII [12, 7]. The apxIV gene is present in all serovars and is the standard target for species-specific molecular detection [12, 1, 13].
Capsule and Lipopolysaccharide
The polysaccharide capsule is a critical factor for antiphagocytosis and survival in the host [4, 14, 8]. The two-component regulatory system CpxA/CpxR positively regulates the cpxDCBA gene cluster, which is required for capsule export [14]. Mutants lacking capsule export genes (e.g., cpxD) are non-capsulated and are strongly attenuated in virulence [14]. Similarly, the O-antigen of LPS, assembled with the involvement of the WecA transferase, contributes to stress resistance and virulence [34].
Adhesins and Surface Structures
Colonization of the porcine respiratory epithelium is mediated by various surface structures. These include type IV pili (e.g., ApfA), outer membrane proteins (OMPs), and autotransporters [4, 15]. The CpxAR system represses apfA expression under heat stress, a mechanism that is important for survival during host fever [15]. Outer membrane vesicles (OMVs) are also released by A. pleuropneumoniae and contain Apx toxins, proteases, and other antigenic proteins that can modulate host immune responses [4, 16].
Biofilm Formation
Biofilm growth is a natural state for A. pleuropneumoniae during infection and is critical for persistence in the host environment [17, 18]. The biofilm matrix includes extracellular polymeric substances (EPS) and requires the production of poly-β-1,6-N-acetylglucosamine (PGA) and its degrading enzyme dispersin B (DspB) for normal structural maturation [17]. Compared to planktonic cells, biofilm cells show reduced central metabolism but upregulate fermentation and EPS synthesis pathways, with global regulators Fnr (HlyX) and Fis playing key roles [17]. Importantly, A. pleuropneumoniae can survive in multi-species biofilms within farm drinking water systems, suggesting an environmental reservoir that facilitates transmission [18].
Iron Acquisition and Stress Resistance
The pathogen scavenges iron from the host environment, and the Dps-like protein FtpA plays a dual role in iron storage and resistance to oxidative stress by oxidizing and mineralizing Fe2+, thereby preventing Fenton chemistry-mediated damage [19]. Another outer membrane protein, OmpW, influences oxidative tolerance and susceptibility to certain antibiotics [20].
Two-Component Regulatory Systems
Several two-component regulatory systems (TCS) are vital for App pathogenesis. The CpxA/CpxR system controls envelope stress responses and capsule export [14, 34]. The NarQ/P system is critical for anaerobic growth and pathogenicity by enabling the use of nitrate as a terminal electron acceptor, a metabolic adaptation that is important in the hypoxic environment of inflamed necrotic tissues [21]. The CopA P-type ATPase provides resistance to copper toxicity, a host defense mechanism [22].
Antimicrobial Resistance
Antimicrobial resistance (AMR) is an increasing concern in A. pleuropneumoniae management [23, 12, 24, 5]. Resistance to florfenicol, tetracycline, and trimethoprim-sulfamethoxazole is frequently reported in field isolates [23]. The florfenicol resistance gene floR is often carried on small plasmids (e.g., pFA11, pMAF5, pMAF6), which can be horizontally transferred among A. pleuropneumoniae and Pasteurella multocida isolates [23]. Quinolone resistance arises through a combination of mechanisms, including mutations in the quinolone resistance-determining region (QRDR) of DNA gyrase and topoisomerase IV, upregulation of efflux pump genes (e.g., acrB), and downregulation of porin genes (e.g., ompP2B, lamB) [25]. Beta-lactam and tetracycline resistance is frequently observed in certain serovars, such as serovar 13, which may promote their clonal spread [12]. Ceftiofur and tiamulin resistance remains rare [23].
Molecular Diagnostics and Serotyping
Rapid and accurate detection and serotyping are essential for disease control [9, 13, 26, 27].
Species-Specific Detection
The species-specific marker gene apxIVA is the gold standard target for PCR-based diagnostics [1, 13]. However, due to the potential for mutations within this marker, additional highly conserved and specific genomic targets have been identified, including genes such as eamA, nusG, sppA, xerD, ybbN, ycfL, and ychJ [13]. Alternative detection platforms include a CRISPR/Cas12a-assisted rapid detection platform (Card) that combines recombinase polymerase amplification (RPA) with Cas12a ssDNase activation, achieving a detection limit of 10 CFU and offering naked-eye or lateral flow readouts for point-of-care use [26].
Serotyping
Traditional serotyping is performed using serological methods, but molecular serotyping via multiplex PCR (mPCR) targeting capsule-specific genes has become the standard [6, 9, 27]. The mPCR assays have been sequentially expanded to cover all 19 known serovars [6]. A high-resolution melting (HRM) assay has also been developed, which distinguishes 13 serovars based on their specific melting temperatures and can be used to identify potential novel serovars through aberrant melting patterns [9]. For field sampling, DNA can be captured on FTA cards from cultured isolates or directly from lesioned lung tissue, allowing for stable storage at 37°C for months and direct use in mPCR without DNA extraction [27].
Whole Genome Sequencing
Whole genome sequencing (WGS) is increasingly used for high-resolution epidemiological surveillance [24, 8]. Comparative genomics has revealed a well-conserved core genome across serovars, with diversity concentrated in CPS, LPS, and RTX-toxin loci, as well as in phage insertions and plasmids [24, 8]. WGS-based analyses can determine serovar in silico, identify AMR genes and plasmids, and differentiate between closely related strains [24]. The presence of phase-variable DNA methyltransferases (phasevarions) that control genome-wide methylation patterns has been discovered, adding a further layer of epigenetic regulation that affects phenotypic diversity and pathobiology [28].
Differential Diagnosis
The clinical presentation of porcine pleuropneumonia overlaps with other swine respiratory diseases. Key differentials include infections caused by Mycoplasma hyopneumoniae (enzootic pneumonia), Pasteurella multocida, Bordetella bronchiseptica, and swine influenza virus [35]. A diagnostic workflow is shown in Figure 1.
graph TD
A[Clinical Signs: Fever, Dyspnea, Cough, Sudden Death], > B{Post-mortem Lung Lesions?};
B, Yes, > C[Fibrinohemorrhagic Necrotizing Pleuropneumonia];
C, > D[Sample: Lung Tissue, Pleural Fluid, or FTA Card Imprint];
D, > E[Molecular Diagnostics];
E, > F[qPCR/CRISPR-Card for apxIV (Species Confirmation)];
E, > G[mPCR for Capsule Serotyping (Serovars 1-19)];
E, > H[Optional: WGS for AMR & Epidemiology];
F, > I[Confirmed App Case];
G, > I;
H, > I;
B, No, > J[Consider Differential Diagnosis];
J, > K[Mycoplasma hyopneumoniae];
J, > L[Pasteurella multocida];
J, > M[Swine Influenza Virus];
Vaccination and Control
Vaccination is a cornerstone of control, but no universally protective vaccine exists due to serovar diversity [4, 2, 11, 29]. Commercial vaccines include bacterins combined with Apx toxoids and subunit toxoid vaccines [29]. Field studies have demonstrated that a bacterin-toxoid vaccine can be superior to a subunit toxoid vaccine in reducing pleurisy lesions and mortality [29]. Vaccination programs have been shown to dramatically reduce the percentage of lungs affected by dorsocaudal pleurisy from over 40% to less than 5%, along with a significant decrease in bronchopneumonia [11]. However, the presence of phasevarions and the ability to modulate surface antigen expression present further challenges for the development of broadly protective subunit vaccines [28].
Frequently Asked Questions (FAQ)
What is the primary host of Actinobacillus pleuropneumoniae?
The domestic pig (Sus scrofa domesticus) is the only known natural host for this pathogen [1].
How many serovars of A. pleuropneumoniae have been described?
There are currently 19 recognized serovars, classified based on capsular polysaccharide and O-antigen diversity [6, 8].
Which toxin genes are used for species-specific PCR detection?
The apxIV gene is the most common species-specific marker, as it is present in all pathogenic serovars and absent in closely related species [1, 13].
What is the mechanism of florfenicol resistance in A. pleuropneumoniae?
Resistance is primarily mediated by the floR gene, which is often carried on small transmissible plasmids [23].
Can A. pleuropneumoniae survive outside the host?
Yes, the bacterium has been detected in multi-species biofilms in farm drinking water, demonstrating its ability to persist in the environment [18].
Is there an effective commercial vaccine against all serovars?
No, current vaccines provide serovar-specific protection and do not offer complete coverage against all 19 serovars [2, 29].
What characterizes a peracute infection?
Peracute infections can cause death within 6 hours of the onset of clinical signs, often before any observable respiratory distress [1].
How does the CpxAR system contribute to virulence?
CpxAR is essential for capsule export, survival under heat stress, and resistance to oxidative and osmotic stresses, making it a critical regulator of full virulence [14, 15, 34].
References
[1] Stringer, O. W., Li, Y., Bossé, J., et al. (2022). JMM Profile: Actinobacillus pleuropneumoniae: a major cause of lung disease in pigs but difficult to control and eradicate. Journal of Medical Microbiology. Link
[2] Nahar, N., Turni, C., Tram, G., et al. (2021). Actinobacillus pleuropneumoniae: The molecular determinants of virulence and pathogenesis. Advances in Microbial Physiology. Link
[3] CABI Compendium. (2022). Actinobacillus pleuropneumoniae. CABI Compendium. Link
[4] Soto Perezchica, M. M., Guerrero Barrera, A. L., Avelar González, F. J., et al. (2023). Actinobacillus pleuropneumoniae, surface proteins and virulence: a review. Frontiers in Veterinary Science. Link
[5] Sassu, E., Bossé, J., Tobias, T., et al. (2018). Update on Actinobacillus pleuropneumoniae, knowledge, gaps and challenges. Transboundary and Emerging Diseases. Link
[6] Stringer, O. W., Bossé, J., Lacouture, S., et al. (2021). Proposal of Actinobacillus pleuropneumoniae serovar 19, and reformulation of previous multiplex PCRs for capsule-specific typing of all known serovars. Veterinary Microbiology. Link
[7] Schuwerk, L., Hoeltig, D., Waldmann, K., et al. (2021). Sero- and apx-typing of German Actinobacillus pleuropneumoniae field isolates from 2010 to 2019 reveals a predominance of serovar 2 with regular apx-profile. Veterinary Research. Link
[8] Donà, V., Ramette, A., & Perreten, V. (2022). Comparative genomics of 26 complete circular genomes of 18 different serotypes of Actinobacillus pleuropneumoniae. Microbial Genomics. Link
[9] Scherrer, S., Peterhans, S., Neupert, C., et al. (2022). Development of a novel high resolution melting assay for identification and differentiation of all known 19 serovars of Actinobacillus pleuropneumoniae. MicrobiologyOpen. Link
[10] Peterhans, S., Stevens, M., Cernela, N., et al. (2021). Draft Genome Sequences of Two Clinical Actinobacillus pleuropneumoniae Serotype 19 Strains from Pigs in Switzerland. Microbiology Resource Announcements. Link
[11] Sipos, W., Cvjetković, V., Dobrokes, B., et al. (2021). Evaluation of the Efficacy of a Vaccination Program against Actinobacillus pleuropneumoniae Based on Lung-Scoring at Slaughter. Animals. Link
[12] Kardos, G., Sarközi, R., Laczkó, L., et al. (2022). Genetic Diversity of Actinobacillus pleuropneumoniae Serovars in Hungary. Veterinary Sciences. Link
[13] Srijuntongsiri, G., Mhoowai, A., Samngamnim, S., et al. (2022). Novel DNA Markers for Identification of Actinobacillus pleuropneumoniae. Microbiology Spectrum. Link
[14] Liu, F., Yao, Q., Huang, J., et al. (2022). The two-component system CpxA/CpxR is critical for full virulence in Actinobacillus pleuropneumoniae. Frontiers in Microbiology. Link
[15] Liu, F., Peng, W., Yan, K., et al. (2022). CpxAR of Actinobacillus pleuropneumoniae Contributes to Heat Stress Response by Repressing Expression of Type IV Pilus Gene apfA. Microbiology Spectrum. Link
[16] Zhu, Z., Antenucci, F., Winther-Larsen, H. C., et al. (2022). Outer Membrane Vesicles of Actinobacillus pleuropneumoniae Exert Immunomodulatory Effects on Porcine Alveolar Macrophages. Microbiology Spectrum. Link
[17] Zhang, Q., Peng, L., Han, W., et al. (2023). The morphology and metabolic changes of Actinobacillus pleuropneumoniae during its growth as a biofilm. Veterinary Research. Link
[18] Loera-Muro, A., Ramírez-Castillo, F. Y., Moreno-Flores, A. C., et al. (2021). Actinobacillus pleuropneumoniae Surviving on Environmental Multi-Species Biofilms in Swine Farms. Frontiers in Veterinary Science. Link
[19] Tang, H., Zhang, Q., Han, W., et al. (2021). Identification of FtpA, a Dps-Like Protein Involved in Anti-Oxidative Stress and Virulence in Actinobacillus pleuropneumoniae. Journal of Bacteriology. Link
[20] Chen, X., Shao, Z., Wu, L., et al. (2022). Involvement of the Actinobacillus pleuropneumoniae ompW Gene in Confrontation of Environmental Pressure. Frontiers in Veterinary Science. Link
[21] Zhang, Q., Tang, H., Yan, C., et al. (2022). The Metabolic Adaptation in Response to Nitrate Is Critical for Actinobacillus pleuropneumoniae Growth and Pathogenicity under the Regulation of NarQ/P. Infection and Immunity. Link
[22] Peng, W., Yang, X., Yan, K., et al. (2021). CopA Protects Actinobacillus pleuropneumoniae against Copper Toxicity. Veterinary Microbiology. Link
[23] Yao, X., Song, Q., Zhu, W., et al. (2023). Characterization of small plasmids carrying florfenicol resistance gene floR in Actinobacillus pleuropneumoniae and Pasteurella multocida isolates from swine in China. Frontiers in Veterinary Science. Link
[24] Guitart-Matas, J., González-Escalona, N., Maguire, M., et al. (2022). Revealing Genomic Insights of the Unexplored Porcine Pathogen Actinobacillus pleuropneumoniae Using Whole Genome Sequencing. Microbiology Spectrum. Link
[25] Ma, X., Zheng, B., Wang, J., et al. (2021). Quinolone Resistance of Actinobacillus pleuropneumoniae Revealed through Genome and Transcriptome Analyses. International Journal of Molecular Sciences. Link
[26] Luan, T., Wang, L., Zhao, J., et al. (2022). A CRISPR/Cas12a-assisted rapid detection platform by biosensing the apxIVA of Actinobacillus pleuropneumoniae. Frontiers in Microbiology. Link
[27] Stringer, O. W., Bossé, J., Lacouture, S., et al. (2021). Rapid Detection and Typing of Actinobacillus pleuropneumoniae Serovars Directly From Clinical Samples: Combining FTA® Card Technology With Multiplex PCR. Frontiers in Veterinary Science. Link
[28] Nahar, N., Tram, G., Jen, F., et al. (2022). Actinobacillus pleuropneumoniae encodes multiple phase-variable DNA methyltransferases that control distinct phasevarions. bioRxiv. Link
[29] Hölzen, P., Warnck, T., Hoy, S., et al. (2021). Comparison of Protectivity and Safety of Two Vaccines against Actinobacillus pleuropneumoniae in a Field Study. Agriculture. Link
[30] Bao, C., Liu, B., Zhu, R., et al. (2021). IFN-γ–/– Mice Resist Actinobacillus pleuropneumoniae Infection by Promoting Early Lung IL-18 Release and PMN-I Accumulation. Infection and Immunity. Link
[31] Wang, L., Zhao, X., Zhu, C., et al. (2020). The antimicrobial peptide MPX kills Actinobacillus pleuropneumoniae and reduces its pathogenicity in mice. Veterinary Microbiology. Link